Xcout Intel
Biodesix, Inc.
Biodesix, Inc. is a public diagnostic solutions company founded in 2006 and headquartered in Louisville, Colorado. The company specializes in diagnostic testing and development services focused on discovering blood-based tests for cancer management.
Subscribe to see Biodesix, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Biodesix, Inc. at a glance
Biodesix, Inc. is a medical - diagnostics & research company headquartered in Louisville, United States. It is publicly listed (BDSX) with a market capitalisation of $297M. Xcout tracks 18 named people at Biodesix, Inc., including Scott Hutton (President, Chief Executive Officer & Director).
Biodesix, Inc. leadership
- Scott HuttonPresident, Chief Executive Officer & Director
- Robin Harper CowieChief Financial Officer, Secretary & Treasurer
- Kieran O'KaneChief Commercial Officer
- Bobbi CoffinChief Growth Officer
- Gary Anthony PestanoChief Scientific Officer
- James R. JettCo-Chief Medical Officer
12 more named people on record for Biodesix, Inc., with roles, board committees and tenure — see the full roster →
Biodesix, Inc. funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $4.9M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Biodesix, Inc. competitors
A few of Biodesix, Inc.'s closest competitors — see the full list of competitors and alternatives →
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Gene Solutions LLC provides AI-powered genetic testing and multi-dimensional genomics services focused on oncology and reproductive health. The company offers blood-based early cancer detection tests, tumor profiling, and minimal residual disease monitoring for patients and healthcare providers.
Exosome Diagnostics, Inc. is a molecular diagnostics company located in Massachusetts, United States. The company specializes in developing biofluid-based liquid biopsy tests, such as the ExoDx Prostate test, for use in personalized medicine and oncology.
MDNA Life Sciences, Inc. develops non-invasive, blood-based diagnostic tests utilizing patented mitochondrial DNA technology to detect diseases such as cancer at early stages. The company serves patients and healthcare providers by offering accurate screening solutions designed to improve disease detection and reduce the need for unnecessary invasive surgeries.
Protean BioDiagnostics Inc. is a diagnostic company based in the United States that provides advanced cancer profiling systems and laboratory testing services.
Predicine Holdings Ltd provides next-generation liquid biopsy platforms and molecular profiling services for cancer research and precision medicine. The company utilizes proprietary blood- and urine-based assays to analyze circulating tumor DNA and RNA, serving biopharmaceutical partners and clinical researchers in oncology drug development and clinical trials.
Get Biodesix, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Biodesix, Inc. in Xcout Intel
- 18 named people with titles, LinkedIn and board committees
- 1 funding round before the IPO with the investors in each, and who they co-invest with
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access